Literature DB >> 11009447

K(ATP) channel activation reduces the severity of postresuscitation myocardial dysfunction.

W Tang1, M H Weil, S Sun, A Pernat, E Mason.   

Abstract

Postresuscitation myocardial dysfunction has been recognized as a leading cause of the high postresuscitation mortality rate. We investigated the effects of ischemic preconditioning and activation of ATP-sensitive K(+) (K(ATP)) channels on postresuscitation myocardial function. Ventricular fibrillation (VF) was induced in 25 Sprague-Dawley rats. Cardiopulmonary resuscitation (CPR), including mechanical ventilation and precordial compression, was initiated after 4 min of untreated VF. Defibrillation was attempted after 6 min of CPR. The animals were randomized to five groups treated with 1) ischemic preconditioning, 2) K(ATP) channel opener, 3) ischemic preconditioning with K(ATP) channel blocker administered 1 min after VF, 4) K(ATP) channel blocker administered 45 min before induction of ischemic preconditioning, and 5) placebo. Postresuscitation myocardial function, as measured by the rate of left ventricular pressure increase at 40 mmHg, the rate of left ventricular decline, cardiac index, and duration of survival, was significantly improved in both preconditioned and K(ATP) channel opener-treated animals. K(ATP) channel blocker administered 45 min before induction of ischemic preconditioning completely abolished the myocardial protective effects of preconditioning. We conclude that ischemic preconditioning significantly improved post-CPR myocardial function and survival. These results also provide evidence that the myocardial protective effects of ischemic preconditioning are mediated by K(ATP) channel activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009447     DOI: 10.1152/ajpheart.2000.279.4.H1609

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Effects of dexmedetomidine on cerebral circulation and systemic hemodynamics after cardiopulmonary resuscitation in dogs.

Authors:  Hiroki Iida; Mami Iida; Hiroto Ohata; Tomohiro Michino; Shuji Dohi
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

2.  A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique.

Authors:  Lorissa Lamoureux; Jeejabai Radhakrishnan; Raúl J Gazmuri
Journal:  J Vis Exp       Date:  2015-04-26       Impact factor: 1.355

3.  Role of KATP channel in electrical depression and asystole during long-duration ventricular fibrillation in ex vivo canine heart.

Authors:  Tyson G Taylor; Paul W Venable; Junko Shibayama; Mark Warren; Alexey V Zaitsev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-30       Impact factor: 4.733

4.  Postresuscitation myocardial dysfunction: correlated factors and prognostic implications.

Authors:  Wei-Tien Chang; Matthew Huei-Ming Ma; Kuo-Liong Chien; Chien-Hua Huang; Min-Shan Tsai; Fuh-Yuan Shih; Ann Yuan; Kuang-Chau Tsai; Fang-Yue Lin; Yuan-Teh Lee; Wen-Jone Chen
Journal:  Intensive Care Med       Date:  2006-11-15       Impact factor: 17.440

5.  Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.

Authors:  Derek J Hausenloy; Gary Baxter; Robert Bell; Hans Erik Bøtker; Sean M Davidson; James Downey; Gerd Heusch; Masafumi Kitakaze; Sandrine Lecour; Robert Mentzer; Mihaela M Mocanu; Michel Ovize; Rainer Schulz; Richard Shannon; Malcolm Walker; Gail Walkinshaw; Derek M Yellon
Journal:  Basic Res Cardiol       Date:  2010-09-24       Impact factor: 17.165

6.  Outcome of prolonged ventricular fibrillation and CPR in a rat model of chronic ischemic left ventricular dysfunction.

Authors:  Xiangshao Fang; Lei Huang; Shijie Sun; Max Harry Weil; Wanchun Tang
Journal:  Biomed Res Int       Date:  2013-12-17       Impact factor: 3.411

7.  Metabolic determinants of electrical failure in ex-vivo canine model of cardiac arrest: evidence for the protective role of inorganic pyrophosphate.

Authors:  Junko Shibayama; Tyson G Taylor; Paul W Venable; Nathaniel L Rhodes; Ryan B Gil; Mark Warren; Adam R Wende; E Dale Abel; James Cox; Kenneth W Spitzer; Alexey V Zaitsev
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.